NDC 0074-3753

Tridione

Trimethadione

Tridione is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Trimethadione.

• Product ID: 0074-3753_7c8d4a8a-ca2c-d7e5-0fa5-f477c9a22822
• NDC: 0074-3753
• Product Type: Human Prescription Drug
• Proprietary Name: Tridione
• Generic Name: Trimethadione
• Dosage Form: Tablet, Chewable
• Route of Administration: ORAL
• Marketing Start Date: 1946-01-25
• Marketing End Date: 2020-04-12
• Marketing Category: NDA / NDA
• Application Number: NDA005856
• Labeler Name: AbbVie Inc.
• Substance Name: TRIMETHADIONE
• Active Ingredient Strength: 150 mg/1
• Pharm Classes: Decreased Central Nervous System Disorganized Electrical Activity [PE],Anti-epileptic Agent [EPC]
• NDC Exclude Flag: N

Packaging

NDC 0074-3753-01

100 TABLET, CHEWABLE in 1 BOTTLE (0074-3753-01)

• Marketing Start Date: 2014-03-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0074-3753-01 [00074375301]

Tridione TABLET, CHEWABLE

• Marketing Category: NDA
• Application Number: NDA005856
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2014-03-26
• Marketing End Date: 2020-04-12

Drug Details

Active Ingredients

Ingredient	Strength
TRIMETHADIONE	150 mg/1

OpenFDA Data

• SPL SET ID: b9322f58-ffcc-4831-5381-93a535b49a09
• Manufacturer:
  • AbbVie Inc.
• UNII:
  • R7GV3H6FQ4
• RxNorm Concept Unique ID - RxCUI:
  • 208594
  • 198330
• UPC Code:
  • 0300743753011

Pharmacological Class

• Decreased Central Nervous System Disorganized Electrical Activity [PE]
• Anti-epileptic Agent [EPC]